Access cutting-edge solid tumors treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Middletown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is an effective treatment for advanced dMMR solid tumors. The study will also look at the safety of the study drug.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this solid tumors clinical trial in Middletown, NJ
If you're searching for solid tumors treatment options in Middletown, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.